|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
χ<sup>2</sup> tests showed that XRCC1-194, XRCC1-280 and XPD-312 gene polymorphisms were significantly correlated with the number, location and diameter of the tumors (p<0.05).
|
28927037 |
2017 |
|
Occupational Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
[Relation of genetic polymorphism of XRCC1 with risks of chronic benzene poisoning].
|
15612468 |
2004 |
|
Micronuclei, Chromosome-Defective
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Genetic polymorphism of XRCC1 associated with susceptibility of chromosomal damage in workers exposed by 1,3-butadiene].
|
21351625 |
2010 |
|
Micronuclei, Genotoxicant-Induced
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[Genetic polymorphism of XRCC1 associated with susceptibility of chromosomal damage in workers exposed by 1,3-butadiene].
|
21351625 |
2010 |
|
Glioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Yet, it is necessary to conduct future prospective explorations to gain a better insight into the impact of XRCC1 Arg399Gln polymorphism on glioma risk.
|
24258108 |
2014 |
|
Lung Neoplasms
|
0.100 |
GeneticVariation
|
group |
LHGDN |
XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers.
|
18407370 |
2008 |
|
Lung Neoplasms
|
0.100 |
GeneticVariation
|
group |
LHGDN |
XRCC1 polymorphism and lung cancer risk.
|
18999926 |
2008 |
|
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.
|
28002403 |
2017 |
|
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.
|
28002403 |
2017 |
|
Mesothelioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
XRCC1 deficiency sensitizes human lung epithelial cells to genotoxicity by crocidolite asbestos and Libby amphibole.
|
20705543 |
2010 |
|
Squamous cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population.
|
17556064 |
2007 |
|
Adenocarcinoma
|
0.080 |
GeneticVariation
|
group |
LHGDN |
XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
|
17264068 |
2007 |
|
Malignant neoplasm of urinary bladder
|
0.100 |
Biomarker
|
disease |
BEFREE |
XPD and XRCC1 appear to have no impact on the risk of bladder cancer.
|
11304692 |
2001 |
|
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
XPD and XRCC1 appear to have no impact on the risk of bladder cancer.
|
11304692 |
2001 |
|
Carcinoma of bladder
|
0.100 |
Biomarker
|
disease |
BEFREE |
XPD and XRCC1 appear to have no impact on the risk of bladder cancer.
|
11304692 |
2001 |
|
Malignant neoplasm of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
Xeroderma pigmentosum group D (XPD) and X-ray repair cross-complementing 1 (XRCC1) genes are 2 important susceptibility genes related to lung cancer.
|
25308691 |
2016 |
|
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
Xeroderma pigmentosum group D (XPD) and X-ray repair cross-complementing 1 (XRCC1) genes are 2 important susceptibility genes related to lung cancer.
|
25308691 |
2016 |
|
Primary malignant neoplasm of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
Xeroderma pigmentosum group D (XPD) and X-ray repair cross-complementing 1 (XRCC1) genes are 2 important susceptibility genes related to lung cancer.
|
25308691 |
2016 |
|
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) plays a key role in DNA repair, genetic instability, and tumorigenesis.
|
25582318 |
2015 |
|
Malignant neoplasm of prostate
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism (rs25487) has been reported to be related to Pca.
|
25262700 |
2015 |
|
Prostate carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism (rs25487) has been reported to be related to Pca.
|
25262700 |
2015 |
|
Malignant neoplasm of skin
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) and group 3 (XRCC3) polymorphisms are relatively frequent in Caucasian populations and may have implications in skin cancer modulation.
|
25218703 |
2014 |
|
Malignant neoplasm of stomach
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
|
21216841 |
2011 |
|
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
|
21216841 |
2011 |
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
X-ray repair cross-complementing group 1 (XRCC1) plays an important role in base excision and single-strand break repair, as a scaffold protein that brings together proteins of the DNA repair complex, and appears to be a candidate for cancer risk.
|
19465687 |
2009 |